For almost 40 years, Duke University has been internationally recognized for outstanding immunological research and training. Duke immunologists and their trainees have made significant contributions to basic and clinical immunobiology. To continue this tradition of excellence and sustain its growth, the proposed Duke University Training Program in Basic Immunology will provide outstanding pre- and postdoctoral training in fundamental immunology, preparing young investigators by providing the intellectual framework and research skills necessary for first-rate science. The proposed Training Faculty is comprised of 27 immunologists who hold primary or secondary appointments in the Department of Immunology. A selections committee (SC) will choose outstanding predoctoral trainees from the students accepted into the Duke Graduate Program in Immunology. These highly capable students will enter a graduate program based on a carefully chosen core curriculum that provides superb grounding in basic immunology, cell and molecular biology, and genetics. Graduate students in the Training Program will be supported for two years, until their admission to doctoral candidacy and the initiation of dissertation research. Postdoctoral applicants will also be selected by the SC from applications to the Training Program or to individual members of the proposed Training Faculty. Postdoctoral fellows may undertake didactic training to augment their preparation for immunological research and will participate in ethics training and Program seminars. For both graduate and postgraduate trainees, the proposed Training Program will stress experimental strategy and design, analysis and interpretation of data, understanding and knowledge of the primary literature, and communication of research findings.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Institutional National Research Service Award (T32)
Project #
5T32AI052077-05
Application #
7091516
Study Section
Allergy & Clinical Immunology-1 (AITC)
Program Officer
Prograis, Lawrence J
Project Start
2002-07-01
Project End
2008-06-30
Budget Start
2006-07-01
Budget End
2008-06-30
Support Year
5
Fiscal Year
2006
Total Cost
$265,095
Indirect Cost
Name
Duke University
Department
Neurosciences
Type
Schools of Medicine
DUNS #
044387793
City
Durham
State
NC
Country
United States
Zip Code
27705
Eudailey, Joshua A; Dennis, Maria L; Parker, Morgan E et al. (2018) Maternal HIV-1 Env Vaccination for Systemic and Breast Milk Immunity To Prevent Oral SHIV Acquisition in Infant Macaques. mSphere 3:
Wills, Saintedym; Hwang, Kwan-Ki; Liu, Pinghuang et al. (2018) HIV-1-Specific IgA Monoclonal Antibodies from an HIV-1 Vaccinee Mediate Galactosylceramide Blocking and Phagocytosis. J Virol 92:
Carico, Zachary M; Roy Choudhury, Kingshuk; Zhang, Baojun et al. (2017) Tcrd Rearrangement Redirects a Processive Tcra Recombination Program to Expand the Tcra Repertoire. Cell Rep 19:2157-2173
Wheaton, Joshua D; Yeh, Chen-Hao; Ciofani, Maria (2017) Cutting Edge: c-Maf Is Required for Regulatory T Cells To Adopt ROR?t+ and Follicular Phenotypes. J Immunol 199:3931-3936
Barclay, William; Shinohara, Mari L (2017) Inflammasome activation in multiple sclerosis and experimental autoimmune encephalomyelitis (EAE). Brain Pathol 27:213-219
Carr, Tiffany M; Wheaton, Joshua D; Houtz, Geoffrey M et al. (2017) JunB promotes Th17 cell identity and restrains alternative CD4+ T-cell programs during inflammation. Nat Commun 8:301
O'Brien, T F; Bao, K; Dell'Aringa, M et al. (2016) Cytokine expression by invariant natural killer T cells is tightly regulated throughout development and settings of type-2 inflammation. Mucosal Immunol 9:597-609
Lykken, Jacquelyn M; Horikawa, Mayuka; Minard-Colin, Veronique et al. (2016) Galectin-1 drives lymphoma CD20 immunotherapy resistance: validation of a preclinical system to identify resistance mechanisms. Blood 127:1886-95
Lykken, Erik Allen; Li, Qi-Jing (2016) The MicroRNA miR-191 Supports T Cell Survival Following Common ? Chain Signaling. J Biol Chem 291:23532-23544
Xu, Xin; Zhang, Yun; Jasper, Jeff et al. (2016) MiR-148a functions to suppress metastasis and serves as a prognostic indicator in triple-negative breast cancer. Oncotarget 7:20381-94

Showing the most recent 10 out of 48 publications